Research on growth hormone (GH) and the insulin-like growth factors (IGFs)
Le Roith
D
D
Sonksen
P H
PH
D000328:Adult; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000209:etiology; D004300:Doping in Sports; D004393:Dwarfism, Pituitary / Q000188:drug therapy; D019382:Human Growth Hormone / Q000009:adverse effects / Q000502:physiology* / Q000627:therapeutic use; D006801:Humans; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000172:deficiency / Q000627:therapeutic use; D009369:Neoplasms / Q000139:chemically induced; D011994:Recombinant Proteins / Q000627:therapeutic use; D012449:Safety; D012955:Societies, Medical; D013002:Somatomedins / Q000502:physiology* / Q000627:therapeutic use
D011994:Recombinant Proteins; D013002:Somatomedins; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I